Protalix (PLX) Enters Deal With Pfizer (PFE) To Develop Gaucher's Disease Treatment
Tweet Send to a Friend
Pfizer (NYSE: PFE) and Protalix (NYSE: PLX) entered into an agreement to develop and commercialize taliglucerase alfa, a plant-cell expressed ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
